Trials / Sponsors / Pharmasoft
Pharmasoft
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | MEXIDOL® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG) Primary Open-Angle Glaucoma (POAG) | Phase 4 | 2023-09-15 |
| Completed | MEXIDOL® in the Rehabilitation Treatment of Patients With Acute Cerebral Failure Ischemic Stroke, Acute | Phase 4 | 2023-04-17 |
| Completed | Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG) Primary Open-Angle Glaucoma (POAG) | Phase 2 | 2021-11-15 |
| Completed | Efficacy and Safety of Mexidol® in Stroke Therapy Ischemic Stroke | Phase 3 | 2019-11-18 |
| Completed | Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral Ischemia Chronic Cerebral Ischemia | Phase 3 | 2019-11-05 |
| Completed | Safety and Efficacy of Mexidol® for ADHD in Children Aged 6-12 Attention Deficit Hyperactivity Disorder (ADHD), Anxiety Disorders and Symptoms | Phase 3 | 2019-07-13 |
| Completed | Study of Efficacy and Safety of MEXIDOL® in Ischemic Stroke Therapy Ischemic Stroke | Phase 3 | 2015-03-06 |